CVS Health receives two CIO distinguished awards
The CIO interactive community recognized CVS Health for excellence and leadership in IT. Read More »
The CIO interactive community recognized CVS Health for excellence and leadership in IT. Read More »
The clinical trial evaluating patritumab as a treatment in non-small cell lung cancer will not proceed to the second part. Read More »
Kalia partners with Benzer Pharmacy to establish franchise in Tampa, Florida. Read More »
Upgraded website, plain language disclosures and frequent updates will help health care providers make informed decisions when purchasing health IT. Read More »
Liver disease therapy Ocaliva granted accelerated approval by FDA. Read More »
IUDs and oral contraceptives donated to help prevent pregnancy in areas affected by the zika virus. Read More »
CVS Pharmacy becomes the exclusive drugstore for the "Partner in Healthy Living" initiative. Read More »
First branded IV antibiotic approved for use with children in more than 10 years. Read More »
Zinbryta approved to treat relapsing forms of MS; only one monthly injection required. Read More »
Initial five stops on the tour announced; second consecutive summer tour to train pharmacists in point-of-care testing. Read More »
The interactive forum brings independent pharmacists together to collaborate on ways to expand business, improve profits and help their patients. Read More »
Webinar compliments NACDS efforts in Puerto Rico to encourage women to discuss the zika virus with their health care providers and pharmacists. Read More »
Expanded exclusion lists also could impact pharmacies, patients. Read More »
Sanofi announced this week that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has recommended the approval of a new drug application from the company. Read More »
The Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency has recommended the approval of saxa/dapa for use in treating type-2 diabetes. Read More »
Incyte Corp. announced that approximately 20 abstracts associated with its clinical developments will be presented at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings in 2016. Read More »
The American Society of Health-System Pharmacists (ASHP) had representatives at a White House meeting regarding opioid abuse this week. Read More »
The U.S. Food and Drug Administration (FDA) announced that it has approved a buprenorphine implant for the treatment of opioid dependence this week. Read More »
CVS Health announced the launch of a digital tool that will allow patients to view wait times at MinuteClinic locations, which is expected to include CVS locations in Target stores later in 2016. Read More »
The Daiichi Sankyo Co. announced this week that it will be joining Takeda Pharmaceutical Limited and Astellas Pharma Inc. in researching the development of a biomarker database. Read More »